Engineering CAR T Cells to Resist Tumor Immune Suppression - Top-Institutions - MDSpire

Engineering CAR T Cells to Resist Tumor Immune Suppression

CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models

  • March 9, 2026

  • 2 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Immuno-oncology
    • Cellular Therapy
    • Gene Editing

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Immunotherapy
    • Cellular Therapy
    • Tumor Microenvironment

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Cellular Therapy
    • Gene Editing
    • Immuno-oncology

  • #4

    Ludwig Maximilians University Munich
    Ludwig Maximilians University Munich

    Munich, Bavaria

    Key Differentiators

    • Tumor Immunology
    • Cellular Therapy
    • Gene Editing

  • #5

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Immunotherapy
    • Cellular Therapy
    • Cancer Research

Original Source(s)

Engineering CAR T Cells to Resist Tumor Immune Suppression

  • March 9, 2026

Related Content

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Biotech exec Jeremy Levin on the industry’s strategic turning point